Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients after elective major abdominal gastrointestinal surgery \[i.e. elective major GI resections, partial or total, especially for cancer, including: esophagectomy, gastrectomy, enterectomy (small bowel resection), colectomy, hepatectomy, pancreatectomy, resections for gall bladder or bile duct cancer (cholangiocarcinoma)\] with pre-existing malnutrition or who are at significant risk for malnutrition or nutrition-related complications\*, with indications for nutritional support
- • 2. Hospitalization on SICU or major surgical ward on the NID
- • 3. Use of EN (nutritional intake provided via tube feeding) and/or PN for at least one day before the NID
- • 4. If patient received oral nutrition (ON) or oral nutrition supplements (ONS) during the observational phase from day -5 to day -2, complete and reliable data of daily caloric and protein intake is available
- • 5. Latest surgical intervention ≤ 10 days before NID
- Exclusion Criteria:
- • 1. Patients with burn injuries
- • 2. Patients requiring postsurgical mechanical ventilation and sedation on the NID
- • 3. Patients receiving ON and/or ONS at any quantity on the day before the NID
- • 4. Patients requiring emergency procedures
Trial Officials
John F Stover, M.D.
Study Chair
Fresenius Kabi
About Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technology, with a strong focus on the areas of intravenous (IV) therapies, infusion devices, and clinical nutrition. With a commitment to enhancing patient care, Fresenius Kabi conducts innovative clinical trials to develop high-quality pharmaceuticals and medical devices that address unmet medical needs. The company leverages its extensive expertise in drug formulation and delivery systems to advance therapeutic solutions across various clinical indications, ensuring safety and efficacy in diverse patient populations. Through its robust research and development initiatives, Fresenius Kabi aims to contribute significantly to the healthcare landscape and improve outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, , Vietnam
Seoul, , Korea, Republic Of
Taipei, , Taiwan
Pune, , India
Taipei, , Taiwan
Manila, , Philippines
Bangkok, , Thailand
Bangkok, , Thailand
Linkou, , Taiwan
Daegu, , Korea, Republic Of
Taichung, , Taiwan
Hyderabad, , India
Quezon City, , Philippines
Seoul, , Korea, Republic Of
Bangalore, , India
Bangkok, , Thailand
Cebu City, , Philippines
Pasig City, , Philippines
Quezon City, , Philippines
Quezon City, , Philippines
Bangkok, , Thailand
Bangkok, , Thailand
Pune, , India
Chennai, , India
Secunderabad, , India
Taichung, , Taiwan
Kaohsiung, , Taiwan
Seoul, , Korea, Republic Of
Kaohsiung, , Taiwan
Chungnam, , Korea, Republic Of
Seoul, , Korea, Republic Of
Manila, , Philippines
Manila, , Philippines
Coimbatore, , India
Daegu, , Korea, Republic Of
Makati City, , Philippines
Surin, , Thailand
Hanoi, , Vietnam
Cebu City, , Philippines
Goyang Si, , Korea, Republic Of
Mohali, , India
Chang Hua, , Taiwan
Chiang Mai, , Thailand
Ho Chi Minh City, , Vietnam
Vellore, , India
Hanoi, , Vietnam
Davao City, , Philippines
Jakarta, , Indonesia
Bombay, , India
Chennai, , India
Dehli, , India
Dehli, , India
Dhakuria, , India
Gurgaon, , India
Gurgaon, , India
Jaipur, , India
Jaipur, , India
Kolkata, , India
Ludhiana, , India
Mohali, , India
Mumbai, , India
Mumbai, , India
New Delhi, , India
Puducherry, , India
Sūrat, , India
Udaipur, , India
Jakarta, , Indonesia
Jakarta, , Indonesia
Jeruk, , Indonesia
Semarang, , Indonesia
Semarang, , Indonesia
Waru, , Indonesia
Yogyakarta, , Indonesia
Yogyakarta, , Indonesia
Seoul, , Korea, Republic Of
Ulsan, , Korea, Republic Of
Cagayan De Oro, , Philippines
Dasmariñas, , Philippines
Manila, , Philippines
Manila, , Philippines
Manila, , Philippines
Quezon City, , Philippines
San Fernando, , Philippines
Kaohsiung City, , Taiwan
Bangkok, , Thailand
Bangkok, , Thailand
Hat Yai, , Thailand
Phuket, , Thailand
Ho Chi Minh City, , Vietnam
Ho Chi Minh City, , Vietnam
Huế, , Vietnam
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials